Methods of producing C-aryl glucoside SGLT2 inhibitors
AssigneeBristol-Myers Squibb Company
InventorsPrashant P. Deshpande, Bruce A. Ellsworth, Janak Singh, Theodor W. Denzel, Chiajen Lai, Gerard Crispino, Michael E. Randazzo, Jack Z. Gougoutas
Life of this patent
Estimating the term…
Abstract
Method for the production of C-aryl glucoside SGLT2 inhibitors useful for the treatment of diabetes and related diseases. and intermediates thereof. The C-aryl glucosides may be complexed with amino acid complex forming reagents.
Claims21
A method of preparing a compound of Formula (I) or a pharmaceutically acceptable complex thereof
- wherein:
- R1 is selected from the group consisting of hydrogen, a hydroxy group, bromine, chlorine, fluorine, an alkyl group, an alkoxy group, an alkylthio group, and an arylthio group, where p is 1 to 4, and with the proviso that bromine, chlorine and fluorine, when present, are only present in at least one of the 3-, 4- and 5-positions;
- R2 is selected from the group consisting of hydrogen, a hydroxy group, chlorine, fluorine, an alkyl group, an alkoxy group, and an alkylthio group, where q is 1 to 5;
- and
- A is selected from the group consisting of a covalent bond, O, S, NH, and (CH2)n where n is 1 to 3, and
- with the proviso that when A is in the 4-position, R1 is not bromine;
- with the proviso that when one of R1 is bromine;
- and
- if A is in the 3- or 6-position, then bromine is in the 5-position,
- if A is in the 2- or 5-position, then bromine is in the 3-position, and
- when bromine is in the 3-position, and A is in the 2- or 5-position, then R1 groups in the 4- and 6-positions are the same and are not bromine, chlorine or fluorine, and
- when bromine is in the 5-position, and A is in the 3- or 6-position, then R1 groups in the 2- and 4-positions are the same and are not bromine, chlorine or fluorine, said method comprising:
- a) forming a compound of Formula (IV) from a lactone protected with an acid-labile protecting group
- wherein ALG is an acid labile protecting group,
- b) glycosidating of the compound of Formula (IV) in the presence of a nucleophilic compound which has an R3 group, with simultaneous removal of the acid-labile protecting group to form a compound of Formula (V);
- wherein R3 is selected from the group consisting of an alkoxy group, an alkenyloxy group, an alkylthio group and an alkenylthio group;
- c) reacting the compound of Formula (V) with an acylating agent to form a compound of Formula (VI);
- d) reducing the compound of Formula (VI) to provide a compound of Formula (VII);
- and
- e) removing acyl protecting group from the compound of Formula (VII) to provide a compound of Formula (I);
- wherein R1, R2, A, p and q are as defined hereinabove, and AC is an acyl protecting group.
A method of preparing a compound of Formula (I) or a pharmaceutically acceptable complex thereof
- wherein:
- R1 is 4-chloro;
- p is 1;
- q is 1;
- A is (CH2)n where n is 1, and
- a) forming a compound of Formula (IV) from a lactone protected with an acid-labile protecting group
- wherein ALG is an acid labile protecting group,
- b) glycosidating the compound of Formula (IV) in the presence of a nucleophilic compound which has an R3 group, which compound is methanol, with simultaneous removal of the acid-labile protecting group to form a compound of Formula (V);
- wherein R3 is methoxy;
- c) reacting the compound of Formula (V) with an acylating agent to form a compound of Formula (VI);
- d) reducing the compound of Formula (VI) to provide a compound of Formula (VII);
- and
- e) removing acyl protecting group from the compound of Formula (VII) to provide a compound of Formula (I);
- wherein R1, R2, A, p and q are as defined hereinabove, and AC is an acyl protecting group.
A method of preparing a compound of Formula (I) or a pharmaceutically acceptable complex thereof
- wherein
- R1 is 4-chloro;
- p is 1;
- R2 is 10-ethyl;
- q is 1;
- A is (CH2)n where n is 1, and
- a0 forming a compound of Formula (IV) from a lactone protected with an acid-labile protecting group
- wherein ALG is an acid labile protecting group and A, R1, p, R2 and q are as defined above;
- b) glycosidating the compound of Formula (IV) in the presence of a nucleophilic compound which has an R3 group, which compound is methanol, with simultaneous removal of the acid-labile protecting group to form a compound of Formula (V);
- wherein R3 is methoxy;
- c) reacting the compound of Formula (V) with an acylating agent to form a compound of Formula (VI);
- d) reducing the compound of Formula (VI) to provide a compound of Formula (VII);
- and
- e) removing acyl protecting group from the compound of Formula (VII) to provide a compound of Formula (I);
- wherein R1, R2, A, p and q are defined hereinabove, and AC is an acyl protecting group.
Dependencies are inferred from the claim text.